Laryxin Honey

Chlorhexidine Dihydrochloride and Lidocaine Hydrochloride Monohydrate, the active ingredients in Laryxin Honey, are an antiseptic and local anesthetic presented as an oromucosal preparation for oral mucosal care. It helps manage infections and provides pain relief in patients with mouth sores or post‑operative oral conditions.

GNH USA supplies Laryxin Honey as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laryxin Honey, containing chlorhexidine and lidocaine, is indicated for conditions affecting the oral mucosa where infection control and pain relief are required.

- Oral mucosal infections: reduces bacterial load and promotes healing of infected lesions. - Mouth sores (aphthous ulcers): provides local analgesia while preventing secondary infection. - Post‑operative oral care: helps prevent infection and eases discomfort after dental or surgical procedures.

Laryxin Honey may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Altered taste sensation: temporary metallic or bitter taste. - Mild oral irritation: burning or tingling at the application site. - Transient numbness: short‑lasting loss of sensation in the mouth. - Dry mouth: reduced salivation during use. - Nausea: occasional feeling of queasiness. - Mild headache: brief discomfort after application.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or angioedema requiring medical attention. - Severe mucosal ulceration: extensive tissue breakdown beyond expected healing. - Anaphylaxis: rapid onset of systemic hypersensitivity, potentially life‑threatening. - Stevens‑Johnson syndrome: rare severe skin and mucous membrane disorder. - Persistent numbness: prolonged loss of sensation beyond expected duration. - Respiratory distress: difficulty breathing associated with an allergic response.

Before using Laryxin Honey, consider the following safety measures.

- Known hypersensitivity: avoid if allergic to chlorhexidine, lidocaine, or any formulation components. - Duration of use: limit to the prescribed period to prevent alteration of normal oral flora. - Monitor irritation: discontinue if severe burning or ulceration develops. - Compromised mucosa: use with caution in patients with extensive oral lesions or mucosal disease. - Concomitant oral antiseptics: do not combine with other chlorhexidine‑containing products to avoid excess exposure. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Laryxin Honey can interact with other agents; awareness helps minimise risk.

Major Interactions (Avoid): - Other topical anesthetics: concurrent use may increase systemic lidocaine exposure. - Alcohol‑based mouthwashes: may heighten mucosal irritation and reduce tolerability. - Additional chlorhexidine products: excess antiseptic exposure can disrupt oral microbiome.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): prolonged mucosal injury may increase bleeding risk; monitor coagulation parameters. - Oral antifungals (e.g., nystatin): chlorhexidine may reduce antifungal efficacy; assess clinical response. - Systemic absorption in damaged mucosa: observe for signs of lidocaine toxicity if large areas are ulcerated.